2003
DOI: 10.1039/b309779j
|View full text |Cite
|
Sign up to set email alerts
|

The syntheses of tricyclic analogues of O6-methylguanine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
4
1
1

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 26 publications
0
10
0
Order By: Relevance
“…Previously, compounds 3a and 3b were obtained in two steps from the appropriate 5-substituted pyrimidine precursors 8 and 9, respectively. 9 Compounds 8 13 and 9 9 were obtained via Michael addition of 2,6-diamino-4(3H)pyrimidinone to the appropriate nitroalkenes which were in turn prepared in 4 steps from 1,3propanediol or 1,4-butanediol respectively. Compounds 8 and 9 were subsequently converted (in 4 steps) to the desired tricyclic pyrrolopyrimidines 3a and 3b.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Previously, compounds 3a and 3b were obtained in two steps from the appropriate 5-substituted pyrimidine precursors 8 and 9, respectively. 9 Compounds 8 13 and 9 9 were obtained via Michael addition of 2,6-diamino-4(3H)pyrimidinone to the appropriate nitroalkenes which were in turn prepared in 4 steps from 1,3propanediol or 1,4-butanediol respectively. Compounds 8 and 9 were subsequently converted (in 4 steps) to the desired tricyclic pyrrolopyrimidines 3a and 3b.…”
Section: Resultsmentioning
confidence: 99%
“…Compounds 8 and 9 were subsequently converted (in 4 steps) to the desired tricyclic pyrrolopyrimidines 3a and 3b. 9 In order to develop a more efficient synthesis of 3b that could also be applied to obtaining the novel sulfur-containing analogues 4a and 4b, we considered an alternative route to 5-substituted pyrrolo [2,3-d]pyrimidines that has been used in the synthesis of the queuine base. 14 This method, which involves the reaction of an a-bromoaldehyde with 2,6-diamino-4(3H)pyrimidinone, allowed the preparation of compounds 10 and 11 in three steps from the respective diols (Scheme 1).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Compound 1 was a weak inactivator (IC 50 1mM) suggesting that it is likely to be recognised as a substrate by the protein. [4] While the analogues are designed as cross-linking agents rather than optimal inactivators of MGMT this demonstrates at least for compound 1 that recognition in DNA is likely and infact is expected to be much better following incorporation into DNA. [1] …”
Section: Biological Activity Of Analogues As Inhibitors Of Mgmtmentioning
confidence: 98%
“…[4] Compounds 6 [5] and 7 [4] were prepared via Michael addition of 2,6-diamino-4(3H)pyrimidinone to the appropriate nitroalkenes which were in turn obtained in four steps from 1,3-propanediol or 1,4-butanediol respectively. The tricyclic pyrrolopyrimidines 4a-b, were prepared via an alternative route in which an appropriate α-bromoaldehyde was condensed with 2,6-diamino-4(3H)pyrimidinone, and the resulting 5-substituted pyrrolopyrimidines subject to thiation at the 4-oxo position and cyclisation via the Mitsunobu reaction.…”
Section: Synthesismentioning
confidence: 99%